
     RDKit          3D

 15 15  0  0  0  0  0  0  0  0999 V2000
   -1.6924    0.3647    0.2623 C   0  0  2  0  0  0  0  0  0  0  0  0
   -2.1042    0.4250   -1.0957 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4937    1.2838    0.5831 C   0  0  1  0  0  0  0  0  0  0  0  0
    0.7580    0.7694   -0.1456 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.9008    1.5771    0.1529 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.9981   -0.6988    0.2476 C   0  0  2  0  0  0  0  0  0  0  0  0
    2.1137   -1.2381   -0.4576 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2653   -1.5340   -0.0142 C   0  0  2  0  0  0  0  0  0  0  0  0
   -1.4154   -0.9813    0.6462 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0663   -2.9704    0.4771 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2279   -3.7483    0.1988 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7701    2.6843    0.2696 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7576    3.7424    1.1300 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0099    4.8735    0.7175 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4447    3.4689    2.5759 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  6
  3  1  1  0
  3 12  1  6
  4  3  1  0
  4  5  1  1
  6  4  1  0
  6  7  1  6
  8  6  1  0
  8 10  1  1
  9  1  1  0
  9  8  1  0
 11 10  1  0
 13 12  1  0
 14 13  2  0
 15 13  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB03740

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT02319

>  <COMMON_NAME>  (1) 
N-acetyl-alpha-D-glucosamine

>  <CAS_NUMBER>  (1) 
10036-64-3

>  <UNII>  (1) 
T13TI5GH3D

>  <SYNONYMS>  (1) 
2-(acetylamino)-2-deoxy-A-D-glucopyranose; 2-(acetylamino)-2-deoxy-α-D-glucopyranose; N-acetyl-α-D-glucosamine; α-D-GlcNAc; α-GlcNAc

$$$$
